Clinical Trial Update: fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD [NA]

View source ↗

Summary

A clinical trial evaluating fNIRs-based neurofeedback to reduce relapse in prescription opioid use disorder and alcohol use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Opioid Use Disorder

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Alcohol Use Disorder, Alcoholism | NA | Status: WITHDRAWN